Skip to content

Clinical trials

Completed Hepatitis C, Chronic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Status: Completed Country / region: Canada Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20042
20054
20064
20078
20084
20094
20103
20118
201210
20141
20152
20164
20176
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche17
AbbVie7
Gilead Sciences7
Boehringer Ingelheim5
Human Genome Sciences Inc.4
BioWest Therapeutics Inc2
Debiopharm International SA2
GlaxoSmithKline2
Kirby Institute2
Vertex Pharmaceuticals Incorporated2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic64
Hepatitis C27
Fibrosis4
Hepatitis4
Acquired Immunodeficiency Syndrome1
Bronchiolitis Obliterans Syndrome1
Hepatitis, Viral, Human1
Infections1
Liver Cirrhosis1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.